We previously reported that melatonin attenuated NAFLD in leptin-deficient mice and in hypercholesteremic Apo E mice by enhancing SIRT1 protein in hepatocytes [40,41]. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.